Acura Pharmaceuticals Common Stock To Trade On The OTCQB Market
15 févr. 2017 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that shares of its...
Acura Pharmaceuticals Exploring Strategic Alternatives
03 janv. 2017 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that it is exploring...
Acura Pharmaceutical Provides Development Update on its LIMITx(TM) Technology
14 déc. 2016 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - December 14, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the U.S. Food...
Acura Pharmaceuticals Announces Third Quarter 2016 Financial Results
14 nov. 2016 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - November 14, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
Acura Pharmaceuticals to Host Third Quarter 2016 Financial Results Conference Call on November 15, 2016
09 nov. 2016 10h30 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - November 09, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company...
KemPharm Announces Licensing Agreement with Acura Pharmaceuticals for Aversion(R) Abuse-Deterrent Technology
18 oct. 2016 06h30 HE
|
Acura Pharmaceuticals, Inc.
CORALVILLE, IA and PALATINE, IL --(Marketwired - October 18, 2016) - KemPharm, Inc. (NASDAQ: KMPH), a clinical-stage specialty pharmaceutical company focused on the discovery and development of...
Acura Pharmaceuticals Announces Second Quarter 2016 Financial Results
08 août 2016 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - August 08, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for...
Acura Pharmaceuticals to Host Webcast on July 14, 2016 to Discuss Additional Data From Study AP-LTX-400
11 juil. 2016 06h30 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - July 11, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company will...
Acura Pharmaceutical's LIMITX(TM) Technology Successfully Confirms Oral Abuse Deterrence Capabilities
08 juin 2016 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - June 08, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results from...
Acura Pharmaceuticals Announces First Quarter 2016 Financial Results
02 mai 2016 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - May 02, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...